Andrew Isaac Geller

Andrew Isaac Geller

Auto-generated profile, based on publicly available information

Andrew Isaac Geller

Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Atlanta Georgia USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AGAndrew I. Geller
Andrew I. Geller
NSNadine Shehab
Nadine Shehab
NWNina J. Weidle
Nina J. Weidle
MLMaribeth C. Lovegrove
Maribeth C. Lovegrove
BWBeverly J. Wolpert
Beverly J. Wolpert
DBDaniel S. Budnitz
Daniel S. Budnitz
Dietary supplements, such as herbal or complementary nutritional products and micronutrients (vitamins and minerals), are commonly used in the United States, yet national data on adverse effects are limited. We used nationally representative surveillance data from 63 emergency departments obtained from 2004 through 2013 to describe visits to U.S. emergency departments because of adverse events related to dietary supplements. On the basis of 3667 cases, we estimated that 23,005 (95% confidence interval [CI], 18,611 to 27,398) emergency department visits per year were attributed to adverse events related to dietary supplements. These visits resulted in an estimated 2154 hospitalizations (95% CI, 1342 to 2967) annually. Such visits frequently involved young adults between the ages of 20 and 34 years (28.0% of visits; 95% CI, 25.1 to 30.8) and unsupervised children (21.2% of visits; 95% CI, 18.4 to 24.0). After the exclusion of unsupervised ingestion of dietary supplements by children, 65.9% (95% CI, 63.2 to 68.5) of emergency department visits for single-supplement–related adverse events involved herbal or complementary nutritional products; 31.8% (95% CI, 29.2 to 34.3) involved micronutrients. Herbal or complementary nutritional products for weight loss (25.5%; 95% CI, 23.1 to 27.9) and increased energy (10.0%; 95% CI, 8.0 to 11.9) were commonly implicated. Weight-loss or energy products caused 71.8% (95% CI, 67.6 to 76.1) of supplement-related adverse events involving palpitations, chest pain, or tachycardia, and 58.0% (95% CI, 52.2 to 63.7) involved persons 20 to 34 years of age. Among adults 65 years of age or older, choking or pill-induced dysphagia or globus caused 37.6% (95% CI, 29.1 to 46.2) of all emergency department visits for supplement-related adverse events; micronutrients were implicated in 83.1% (95% CI, 73.3 to 92.9) of these visits. An estimated 23,000 emergency department visits in the United States every year are attributed to adverse events related to dietary supplements. Such visits commonly involve cardiovascular manifestations from weight-loss or energy products among young adults and swallowing problems, often associated with micronutrients, among older adults. (Funded by the Department of Health and Human Services.)

1 May 2014 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
AGAndrew I. Geller
Andrew I. Geller
NSNadine Shehab
Nadine Shehab
MLMaribeth C. Lovegrove
Maribeth C. Lovegrove
SKScott R. Kegler
Scott R. Kegler
KWKelly N. Weidenbach
Kelly N. Weidenbach
DBDaniel S. Budnitz
Daniel S. Budnitz
Insulin is a cornerstone of type 1 diabetes mellitus (DM) treatment and is increasingly introduced early in the treatment course for patients with type 2 DM, who account for 90% to 95% of new DM cases annually.1 During the last decade, the number of US patients with insulin-treated DM rose 50%; one-third of patients with diabetes currently use insulin,2 and in 2012, insulin was estimated to cost the US health care system approximately $6 billion.3 Tight glycemic control with insulin has been associated with reductions in disease complications among patients with type 1 DM4 but has been increasingly associated with harms among patients with type 2 DM.5-7 Insulin remains one of the most challenging and limiting aspects of DM medical management owing to complexities in dosing and administration, as well as the need for routine monitoring of blood glucose (BG) and food intake to avoid potentially fatal hypoglycemia.8 The risk of insulin-related hypoglycemia is an important consideration when choosing among treatment options and individualizing glycemic targets, particularly in patients for whom benefits of intensive control are not as likely to be realized.9,10

18 January 2022 in Annals of Internal Medicine
Verified
Journal Article
Closed access
ISIsaac See
Isaac See
ALAllison Lale
Allison Lale
PMPaige Marquez
Paige Marquez
MSMichael B. Streiff
Michael B. Streiff
AWAllison P. Wheeler
Allison P. Wheeler
DSDavid K. Shay
David K. Shay
Using the Vaccine Adverse Event Reporting System, the number and demographic characteristics of cases of thrombosis with thrombocytopenia syndrome occurring after receipt of COVID-19 vaccines in th... Visual Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination. Using the Vaccine Adverse Event Reporting System, the number and demographic characteristics of cases of thromb... Background: Thrombosis with thrombocytopenia syndrome (TTS) is a potentially life-threatening condition associated with adenoviral-vectored COVID-19 vaccination. It presents similarly to spontaneou...

20 April 2018 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
AGAndrew I. Geller
Andrew I. Geller
MLMaribeth C. Lovegrove
Maribeth C. Lovegrove
NSNadine Shehab
Nadine Shehab
LHLauri A. Hicks
Lauri A. Hicks
MSMathew R. P. Sapiano
Mathew R. P. Sapiano
DBDaniel S. Budnitz
Daniel S. Budnitz
Detailed, nationally representative data describing high-risk populations and circumstances involved in antibiotic adverse events (AEs) can inform approaches to prevention.

29 March 2023 in Thrombosis Research
Verified
Journal Article
Closed access
AGAndrew I. Geller
Andrew I. Geller
NSNadine Shehab
Nadine Shehab
MLMaribeth C. Lovegrove
Maribeth C. Lovegrove
NWNina J. Weidle
Nina J. Weidle
DBDaniel S. Budnitz
Daniel S. Budnitz

29 October 2019 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
AGAndrew I. Geller
Andrew I. Geller
NSNadine Shehab
Nadine Shehab
MLMaribeth C. Lovegrove
Maribeth C. Lovegrove
KRKathleen O. Rose
Kathleen O. Rose
NWNina J. Weidle
Nina J. Weidle
DBDaniel S. Budnitz
Daniel S. Budnitz